Design and Synthesis of New Quinoxaline Derivatives as Anticancer Agents and Apoptotic Inducers
El Newahie, Aliya M S; Nissan, Yassin M; Ismail, Nasser S M; Abou El Ella, Dalal; Khojah, Sohair M; Abouzid, Khaled;
Abstract
The quinoxaline scaffold is a promising platform for the discovery of active chemotherapeutic agents. Three series of quinoxaline derivatives were synthesized and biologically evaluated against three tumor cell lines (HCT116 human colon carcinoma, HepG2, liver hepatocellular carcinoma and MCF-7, human breast adenocarcinoma cell line), in addition to VEGFR-2 enzyme inhibition activity. Compounds VIId, VIIIa, VIIIc, VIIIe and XVa exhibited promising activity against the tested cell lines and weak activity against VEGFR-2. Compound VIIIc induced a significant disruption in the cell cycle profile and cell cycle arrest at the G2/M phase boundary. In further assays, the cytotoxic effect of the highly active compounds was determined using a normal Caucasian fibroblast-like fetal lung cell line (WI-38). Compound VIIIc could be considered as a lead compound that merits further optimization and development as an anti-cancer and an apoptotic inducing candidate against the HCT116 cell line.
Other data
| Title | Design and Synthesis of New Quinoxaline Derivatives as Anticancer Agents and Apoptotic Inducers | Authors | El Newahie, Aliya M S; Nissan, Yassin M; Ismail, Nasser S M; Abou El Ella, Dalal ; Khojah, Sohair M; Abouzid, Khaled | Keywords | anti-cancer activity; cell cycle; quinoxaline; synthesis | Issue Date | 25-Mar-2019 | Publisher | MDPI | Journal | Molecules (Basel, Switzerland) | Volume | 24 | Issue | 6 | ISSN | 1420-3049 | DOI | 10.3390/molecules24061175 | PubMed ID | 30934622 | Scopus ID | 2-s2.0-85063574116 | Web of science ID | WOS:000465503800137 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.